AMN Healthcare Services vs TrueBlue
AMN and TBI side by side, both in personnel supply services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AMN and TBI compare
AMN Healthcare Services is the larger company, worth 3.9 times as much as TrueBlue ($1.5B against $381M).
AMN Healthcare Services grew revenue faster over the last twelve months (29.5% versus 12.4% for TrueBlue).
AMN Healthcare Services keeps more of each dollar of sales as profit, with a net margin of 3.1% compared with −2.6% at TrueBlue.
AMN Healthcare Services scores higher on the StockData Score (14 against 6 for TrueBlue), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AMN | TBI |
|---|---|---|
| Size and price | ||
| Market cap | $1.5B | $381M |
| Share price | $37.90 | $12.50 |
| Change, 1 year | 118% | 157% |
| Change, 5 years | −68.0% | −52.5% |
| Beta (5Y) | 0.72 | 1.18 |
| Employees | 2,664 | 3,500 |
| StockData Score | ||
| Total score | 14 (better) | 6 |
| Valuation score | 5 (better) | 2 |
| Growth score | 1 | 1 |
| Performance score | 3 (better) | 0 |
| Health score | 5 (better) | 3 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 13.8× | – |
| P/S | 0.4× | 0.2× (better) |
| P/B | 1.9× | 1.4× (better) |
| EV/EBITDA | 5.8× | – |
| P/FCF | 4.5× | – |
| FCF yield | 22.3% (better) | −19.0% |
| Fair value | $55.46 | $14.81 |
| Margin of safety | 31.7% (better) | 15.6% |
| Growth | ||
| Revenue growth (TTM) | 29.5% (better) | 12.4% |
| Revenue growth, 5Y average | 2.7% (better) | −2.6% |
| Profitability | ||
| Gross margin | 28.4% (better) | 20.6% |
| Operating margin | 5.8% (better) | −2.0% |
| Net margin | 3.1% (better) | −2.6% |
| FCF margin | 9.3% (better) | −4.1% |
| Return on equity | 15.4% (better) | −15.9% |
| Return on invested capital | 9.8% (better) | −8.6% |
| Financial health | ||
| Debt / equity | 0.96 | 0.38 (better) |
| Net debt / EBITDA | 1.45 | – |
| Interest coverage | 6.1× | – |
| Current ratio | 1.21 | 2.33 (better) |
| Altman Z-score | 3.29 | 4.02 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 120% | 85.1% |
| Held by insiders | 0.87% | 7.8% |
| Insider net buying, 12 months | −$114K | $134K (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 11.1% | 1.6% |
Go deeper
- AMN stock overview
- AMN income statement
- AMN valuation and score
- TBI stock overview
- TBI income statement
- TBI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.